Solventum Corp. (SOLV)
87.29
+0.88
(+1.02%)
USD |
NYSE |
Oct 09, 16:00
88.30
+1.01
(+1.16%)
After-Hours: 20:00
Solventum Net Income (Quarterly) : 92.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.00M |
| March 31, 2026 | 13.00M |
| December 31, 2025 | 63.00M |
| September 30, 2025 | 1.266B |
| June 30, 2025 | 90.00M |
| March 31, 2025 | 137.00M |
| December 31, 2024 | 30.00M |
| Date | Value |
|---|---|
| September 30, 2024 | 122.00M |
| June 30, 2024 | 89.00M |
| March 31, 2024 | 237.00M |
| December 31, 2023 | 272.00M |
| September 30, 2023 | 460.00M |
| June 30, 2023 | 321.00M |
| March 31, 2023 | 293.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Stryker Corp. | 1.276B |
| Zimmer Biomet Holdings, Inc. | 199.60M |
| Inspire Medical Systems, Inc. | 0.314M |
| Enovis Corp. | -1.036M |
| Edwards Lifesciences Corp. | 241.40M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.209B |
| Total Expenses (Quarterly) | 2.117B |
| EPS Diluted (Quarterly) | 0.5309 |
| Enterprise Value | 19.73B |
| Gross Profit Margin (Quarterly) | 58.44% |
| Profit Margin (Quarterly) | 4.16% |
| Earnings Yield | 9.37% |
| Operating Earnings Yield | 4.62% |
| Normalized Earnings Yield | 10.60 |